Recursion Pharmaceuticals (RXRX) Non-Current Deferred Tax Liability (2023 - 2026)
Recursion Pharmaceuticals' Non-Current Deferred Tax Liability came in at $18.31 million for Q2 2026, down 23.0% from $23.78 million a year earlier but up 0.2% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Non-Current Deferred Tax Liability (2023 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals' Non-Current Deferred Tax Liability was $23.26 million, up 40.3% from FY2024.
- Going back by year, Non-Current Deferred Tax Liability was $16.58 million in FY2024 and $1.34 million in FY2023.
- The five-year range for quarterly Non-Current Deferred Tax Liability is $168,000 (Q3 2024) to $23.78 million (Q2 2025).
- Year-over-year, Non-Current Deferred Tax Liability increased in 1 of the last four quarters, with an average decline of 23.1%.
- Business Quant data shows RXRX's Non-Current Deferred Tax Liability at $18.28 million (Q1 2026), $23.26 million (Q4 2025) and $23.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.31 Mn |
| Mar 31, 2026 | 18.28 Mn |
| Dec 31, 2025 | 23.26 Mn |
| Sep 30, 2025 | 23.31 Mn |
| Jun 30, 2025 | 23.78 Mn |
| Mar 31, 2025 | 22.44 Mn |
| Dec 31, 2024 | 16.58 Mn |
| Sep 30, 2024 | 168,000.00 |
| Mar 31, 2024 | 528,000.00 |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 4.34 Mn |
API Access
Recursion Pharmaceuticals Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();